CRP and COVID-19: A different published case discussing rhabdomyolysis in a 38-year-old male patient with COVID-19 utilized APT, activated partial thromboplastin, lactate dehydrogenase, and C-reactive protein in the care period for the patient [30]. Lactate dehydrogenase and C-reactive protein may help quantify the extent of muscle damage or inflammation, but they’re not specific.